To see whether adding a drug (dexmedetomidine)to the nerve block, provides longer period of pain relief after hip operation.

Efficacy of Dexmedetomidine as an adjuvant in femoral nerve block for post-op pain relief in hip surgery: A randomized control double blind study.

Status

Recruiting

Phases

Phase 4

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2018/02/012137

Enrollment

Registered

2018-02-23

Start date

Unknown

Completion date

Unknown

Last updated

2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: null- Patient with hip fracture,undergoing operation.

Interventions

Intervention1: Group B: USG guided femoral nerve block with 40ml [0.25% bupivacaine + 50 mcg dexmedetomidine (0.5ml)] in affected lower limb and 0.5 ml NS intramuscularly in opposite gluteal area. I

Eligibility

Inclusion criteria

Inclusion criteria: Age group: 18-80y. Belonging to ASA I, II and III. Scheduled to undergo surgery for hip surgery

Exclusion criteria

Exclusion criteria: Patient with : Poly trauma Head injury known cases of bleeding disorders,neuromuscular abnormalities Deformities of the lumbar region. Parents not willing to give consent for the study. Chronic alcoholic and long term steroid therapy. Consuming analgesics and adrenergic agonist or antagonist for a long time. Patient not giving consent for regional anaesthesia

Design outcomes

Primary

Measure	Time frame
Duration of first rescue analgesia after blockTimepoint: Every 4th hours till analgesic requirement	—

Secondary

Measure	Time frame
24hour analgesic requirementTimepoint: Everly 4th hourly till 24 th hour.	—

Countries

India

Contacts

Public ContactDr SAMEER DESAI

SDM College Of Medical Science And Hospitals

sameeranaes@gmail.com02477755

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026